Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Christopher Leahy  LinkedIn

Senior Vice President,
Finance, Piramal Pharma Solutions

Chris Leahy heads the Global Finance function for Piramal Pharma Solutions (PPS) across North America, Europe and India. In his current role, Mr. Leahy is responsible for long term financial strategy, driving profitable growth for the business as well as financial reporting, analysis and internal controls. He has played an active role in M&A transactions, ensuring high returns on various growth capex investments, and helped secure the private equity investment into PPL in 2020.

Mr. Leahy has been with PPS for over a decade and has previously worked with Price Waterhouse Coopers, ICI and Pfizer where he was a Finance Director at a large manufacturing facility. He is a qualified UK Chartered Accountant with over two decades of experience in the Pharmaceutical industry. His experience in Finance include Audit, Financial Planning and Analysis, Financial Reporting, M&A, Taxation, and Procurement, with a strong commercial focus.

Mr. Leahy holds a BSC (Hons) degree in Mathematics from Bristol University (UK).

Leadership Team

Peter DeYoung    LinkedIn

CEO, Piramal Global Pharma

Stuart Needleman    LinkedIn

Chief Commercial Officer &
Chief Patient Centricity Officer, Piramal Pharma Solutions

Herve Berdou    LinkedIn

Chief Operating Officer, Piramal Pharma Solutions

Paolo Fiorino    LinkedIn

Executive Vice President,
North America API and Formulations, Piramal Pharma Solutions

Robert Munday    LinkedIn

Executive Vice President,
Aeseptic and Biologics, Piramal Pharma Solutions

Debashish Chakravorty    LinkedIn

Executive Vice President, India and UK Formulations

Surinder Gulati    LinkedIn

Executive Vice President,
India API and Operations, Piramal Pharma Solutions

Rashida Najmi    LinkedIn

Chief Quality Officer, Piramal Pharma Solutions